National Funds
Project PLEC2022-009319 CNT-inmunocáncer
Descubrimiento y desarrollo temprano de nuevos activadores de CNTs para potenciar la inmunoterapia del cáncer (CNT-inmunocáncer) - LÍNEAS ESTRATÉGICAS 2022
edit_calendar
Duration: from 01 September 2022 to 31 August 2025
(36 months)
Current
With a Public character. It has been granted under a regime of Competitive.
In collaboration with other entities.
